Detect Hereditary Pancreatic Cancer

Sponsored, no-charge genetic testing and counseling for hereditary pancreatic cancer

Targeted medical treatments

Genetic testing of patients with pancreatic cancer may enable targeted medical treatment options and clinical trial enrollment

Family members at risk

Predictive testing can help identify relatives with an elevated risk of cancer who may benefit from earlier and/or increased screening and prevention options.

Increasing access to inherited genetic testing


While genetic testing offers tangible benefits to patients, it’s often underutilized due to cost and accessibility barriers. 


Invitae is addressing these barriers with the Detect Hereditary Pancreatic Cancer program, which offers no-charge, sponsored genetic testing and genetic counseling to eligible patients.

Patient privacy

Invitae is committed to your privacy. We’re HIPAA compliant, which means we follow the same guidelines doctors use in protecting your health information. We’ll also never share any personally identifying information with third-parties without your permission. For more information on how Invitae protects your privacy, please visit our privacy page.

Program Eligibility

This program is available to individuals in the US and Canada with one of the following diagnoses:

  • Pancreatic adenocarcinoma at any age

  • Pancreatic neuroendocrine tumor at any age

Postmortem samples are not permitted through the program at this time

Testing options

The Detect Hereditary Pancreatic Cancer program offers testing with the following three panels:

Invitae BRCA1 and BRCA2 STAT Panel*

This test analyzes the BRCA1 and BRCA2 genes, which are assoicated with hereditary breast and ovarian cancer syndrome (HBOC). Accelerated turnaround time may be necessary because physicians and patients often want to make surgical and management decisions as quickly as possible.

Invitae Common Hereditary Cancers Panel

The Invitae Common Hereditary Cancers Panel analyzes 47 genes associated with cancers of the breast, ovary, uterus, prostate and gastrointestinal system, which includes the stomach, colon, rectum, small bowel, and pancreas. 

Invitae Multi-Cancer Panel

The Invitae Multi-Cancer Panel is a comprehensive cancer panel that tests genes associated with hereditary cancer syndromes, including known pancreatic cancer genes. 

*The Invitae BRCA1 and BRCA2 STAT Panel is optional. If selected, clinicians must also select either the Invitae Multi-Cancer Panel or the Invitae Common Hereditary Cancers Panel. If no additional panel is selected, Invitae will process the Invitae Multi-Cancer Panel by default. Results will be delivered separately in two different reports: the Invitae BRCA1 and BRCA 2 STAT Panel results will be reported within 5-12 days from sample accessioning. Results of the Invitae Multi-Cancer Panel or the Invitae Common Hereditary Cancers Panel will be reported separately within 21 days of delivery of the first report. If the Invitae BRCA1 and BRCA2 STAT Panel is not selected, results will be delivered within normal turnaround times.

How to order

1. Submit an order

To place your online order, click here and follow the on-screen prompts.

To place a paper-based order, download the paper order form and include it in the specimen box. 

2. Collect a specimen

If a specimen collection kit was not ordered during the online ordering workflow, order a blood, buccal, or saliva collection kit here
Please view specimen and shipping requirements for important information. If you chose to do a paper-based order, include the completed paper order form in the box with the specimen. 

3. Receive results

On average, results are available 10-21 days after Invitae receives the specimen. You will receive a notification email once the test results are ready.
Log in to view the status of your online order. 

Next steps and addditional services

STAT Panel testing

If the Invitae BRCA1 and BRCA2 STAT Panel was ordered, clinicians will have selected either the Invitae Multi-Cancer Panel or the Invitae Common Hereditary Cancers Panel as a follow-up test for their patient. If no additional panel was selected, Invitae will process the Invitae Multi-Cancer Panel by default. Results of the follow-up testing will be reported separately within 21 days of delivery of the first report.

To view the results of the follow-up testing, please click here to log in to your account below.

Multi-Cancer or Common Hereditary Panel testing

If the Invitae Multi-Cancer Panel or the Invitae Common Hereditary Cancers Panel was ordered, Detect Hereditary Pancreatic Cancer includes one re-requisition within  90 days to another panel in the original clinical area.

Click here to log into your account, navigate to the order, and click "Add rerequisition"

Family variant testing for familial insights

If a positive result is identified, testing for your patient's family members is available. 

Click here and simply follow the ordering instructions, selecting only the gene(s) you are interested in testing for the family member. The partner code will automatically be added with the order. 

Are you a patient?

If you're a patient and believe you are eligible for this sponsored testing program, you have options:

Contact Genome Medical
(available in US only)

Schedule a genetic counseling session, by phone or video, with an expert who can review your testing options and place the order. There is a cost associated with the Genome Medical services, which may be covered under your health benefits.

Discuss the program with your doctor

If you already have a healthcare provider who can place this order, you can download this flyer to take to your own provider.

Find a local genetics provider

Search our genetics providers network to find a provider in your area. Please sign in, or create an account, to connect with our network of professionals. There may be a cost associated with the provider’s services.

Support every step of the way

Client services

Available to answer your questions or help you through the testing process.

  • Monday-Friday 5:00 am to 5:00 pm Pacific

  • Phone: 800-436-3037

Genetic counseling

Individuals tested through the Detect Hereditary Pancreatic Cancer program will be eligible for no-charge, post-test genetic counseling to help them understand their test results. Invitae's genetic counseling services include:

  • Review of the patient's medical history and family history
  • Review of the patient’s genetic test results and the implications of those results for the patient and their family
  • A detailed consult note and pedigree made available to the patient and clinician after the genetic counseling session is complete


About Invitae

Invitae is a genetic information company whose mission is to bring genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene tests today.


While third parties and commercial organizations may provide financial support for this program, tests and services are performed by Invitae. Healthcare professionals must confirm that patients meet certain criteria to use the program. Third parties and commercial organizations may receive de-identified patient data from this program, but at no time would they receive patient identifiable information. Third parties and commercial organizations may receive contact information for healthcare professionals who use this program. Genetic testing and counseling are available in the US and Canada only. Healthcare professionals and patients who participate in this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use, or support any other products or services from Invitae or from third parties or commercial organizations.

1. Hu C, et al. JCO Precis Oncol. 2018;2:10.